Baxter's fourth quarter of 2025 saw total sales rise 8% year over year to $2.97 billion. The company's net income from continuing operations not in accordance with generally accepted accounting ...

Kevin Baxter writes about soccer and hockey for the Los Angeles Times. He has covered seven World Cups, five Olympic Games, six World Series and a Super Bowl and has contributed to three Pulitzer ...

Baxter calculates forward-looking non-GAAP financial measures based on forecasts that omit certain amounts that would be included in GAAP financial measures. For instance, forward-looking organic ...

Thank you for reporting this station. We will review the data in question. You are about to report this weather station for bad data. Please select the information that is incorrect.

Thank you, John! We’re thrilled to hear you had such an amazing experience with Isaac and Mitch here at Baxter Ford West Dodge. They’ll be excited to know they helped you find a truck you love.

Feb 12 (Reuters) - Baxter (BAX.N), opens new tab forecast annual profit well below Wall Street expectations on Thursday, bracing for a year marked by uncertainty around its infusion pump business and ...

Shares of Baxter International fell sharply Thursday after the medical device company reported weaker-than-expected quarterly earnings and issued a dim outlook for 2026. Baxter reported adjusted ...

Fourth-quarter sales from continuing operations of $2.97 billion increased 8% on a reported basis and 3% on an operational basis 1,2 Fourth-quarter U.S. GAAP 3 diluted earnings per share (EPS) (loss) ...

The dialysis market is expected to expand at a compound annual growth rate (CAGR) of around 8% over the forecast period. This ...

Gift Article 10 Remaining As a subscriber, you have 10 articles to gift each month. Gifting allows recipients to access the article for free. Baxter CEO Andrew Hider is seeing his company take a ...

Its final quarter of 2025 was mixed, with a notable whiff on earnings. On the plus side, it notched a convincing beat on revenue. Baxter's fourth quarter of 2025 saw total sales rise 8% year over year ...